Guhan Pharmaceutical announced that Jiang Yi, the chairman and president of the company, applied to resign as president and remained the company's chairman even after his resignation. The company held an interim meeting of the 11th board of directors on November 10, 2026 to review and approve the appointment of Hu Qilong as the company's president. The term of office begins on the date of review and approval by the board of directors and ends on the date the term of the eleventh board of directors expires.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.